Two studies have confirmed previous observations that an inverse relationship exists between chronological age and focal white-matter inflammatory activity in individuals with multiple sclerosis, which could underlie the relative ineffectiveness of traditional disease-modifying therapies in older individuals.
References
Rae-Grant, A. et al. Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90, 789–800 (2018).
Weideman, A. M., Tapia-Maltos, M. A., Johnson, K., Greenwood, M. & Bielekova, B. Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments. Front. Neurol. 8, 577 (2017).
Segal, B. M. CNS chemokines, cytokines, and dendritic cells in autoimmune demyelination. J. Neurol. Sci. 228, 210–214 (2005).
Tortorella, C. et al. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis. J. Neurol. Sci. 239, 95–99 (2005).
Tremlett, H., Zhao, Y., Joseph, J. & Devonshire, V., the UBCMS Clinic Neurologists. Relapses in multiple sclerosis are age- and time-dependent. J. Neurol. Neurosurg. Psychiatry 79, 1368–1374 (2008).
Lassmann, H. Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front. Immunol. 9, 3116 (2019).
Strijbis, E. M. et al. Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry https://doi.org/10.1136/jnnp-2022-330887 (2023).
Coerver, E. et al. Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long-term follow-up. Eur. J. Neurol. https://doi.org/10.1111/ene.15862 (2023).
Bsteh, G. et al. Discontinuation of disease-modifying therapies in multiple sclerosis-clinical outcome and prognostic factors. Mult. Scler. 23, 1241–1248 (2017).
Bebo, B. et al. The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs. Neurology 98, e1810–e1817 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Segal, B.M. Inverse association between age and inflammatory disease activity in multiple sclerosis. Nat Rev Neurol 19, 577–578 (2023). https://doi.org/10.1038/s41582-023-00844-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-023-00844-9
- Springer Nature Limited